# Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

> **NCT00446680** · PHASE3 · COMPLETED · sponsor: **Syntara** · enrollment: 340 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Mannitol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00446680
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2010-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446680, "Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00446680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*